About Synapse Medicine
Synapse Medicine is a company based in Bordeaux (France) founded in 2017. Synapse Medicine has raised $38.81 million across 3 funding rounds from investors including BNP Paribas, Bpifrance and Korelya Capital. Synapse Medicine offers products and services including Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry. Synapse Medicine operates in a competitive market with competitors including Wellth, Kinsa, Cureatr, Phil and Capsa Healthcare, among others.
- Headquarter Bordeaux, France
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$38.81 M (USD)
in 3 rounds
-
Latest Funding Round
$27.98 M (USD), Series B
Mar 01, 2022
-
Investors
BNP Paribas
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synapse Medicine
Synapse Medicine offers a comprehensive portfolio of products and services, including Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry.
Provides medication suggestions as user types.
Enables personalized prescriptions based on clinical conditions.
Allows quick input of drug allergies through autocomplete.
Detects interactions and contraindications for safer prescribing.
Facilitates entering dosing specifics for medications.
People of Synapse Medicine
Unlock access to complete
Funding Insights of Synapse Medicine
Synapse Medicine has successfully raised a total of $38.81M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $27.98 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Synapse Medicine
Synapse Medicine has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include BNP Paribas, Bpifrance and Korelya Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on investing in tech startups
|
Locked | Locked | Locked | |
|
Venture capital fund focused on tech companies
|
Locked | Locked | Locked | |
|
Venture capital is provided to French companies by the firm.
|
Locked | Locked | Locked |
Investor details for Synapse Medicine
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synapse Medicine
Investment portfolio details for Synapse Medicine
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synapse Medicine
Detailed financials for Synapse Medicine
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synapse Medicine Comparisons
Peer comparison for Synapse Medicine
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synapse Medicine
Synapse Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wellth, Kinsa, Cureatr, Phil and Capsa Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides AI and cloud-based platform for doctors for patient engagement and care
|
|
| Locked | Locked | Locked |
Thermometers and mobile apps are provided for tracking fever symptoms.
|
|
| Locked | Locked | Locked |
Cloud-based medication management software is provided for healthcare providers.
|
|
| Locked | Locked | Locked |
Prescription drugs refill management solutions
|
|
| Locked | Locked | Locked |
Medication management systems are supplied to healthcare providers and pharmacies.
|
|
| Locked | Locked | Locked |
Medication management is specialized for chronic disease patients.
|
Detailed competitors of Synapse Medicine
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synapse Medicine
Complete news archive for Synapse Medicine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synapse Medicine
Synapse Medicine was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Synapse Medicine is headquartered in Bordeaux, France.
Clement Goehrs is the current CEO of Synapse Medicine.
Synapse Medicine is a funded company, having raised a total of $38.81M across 3 funding rounds to date.
Synapse Medicine was founded in 2017 in Bordeaux, France, within the health technology sector. A virtual assistant for drug prescription is offered through the platform, along with information on medical errors. These resources are delivered to healthcare professionals, telemedicine companies, hospitals, and other facilities to support clinical decision-making and error prevention across operations.
Synapse Medicine's top competitors include Wellth, Phil and Capsa Healthcare.
Synapse Medicine offers Drug Information Monographs, Patient Clinical Profile, Allergy Search, Drug Interactions Analysis, and Order Entry.
Synapse Medicine has 8 investors. Key investors include BNP Paribas, Bpifrance, Korelya Capital, XAnge, and MACSF.